QGRW closed at $66.90 on August 25, up 0.6% on the day and 5.5% higher over the past month, as the WisdomTree U.S. Quality Growth Fund rides a broader recovery in growth-oriented equities.
The headline tension this week is a mismatch between the short interest headline number and the actual lending picture. Short interest jumped 32% over the week to roughly 75,000 shares — and has nearly doubled over the past month. That sounds alarming until you look at context: those shares represent just 0.21% of the free float. This is, in absolute terms, a negligible short position. The borrow market confirms it. Availability is extraordinarily loose — over 1,100% of current short interest, meaning there are more than eleven shares available to lend for every one currently borrowed. The 52-week tightest point reached just 6.8%, so the lending pool has never come close to stress. Cost to borrow is a modest 2.2%, roughly flat on the week and down slightly over the month. The ORTEX short score of 29.8 sits in a calm range, having crept up from around 26 a fortnight ago but showing no sign of acceleration. The short story here is not crowding — it is almost certainly ETF-level arbitrage activity or routine hedging noise.
Options positioning reinforces the low-conviction, low-drama read. The put/call ratio of 0.17 is essentially in line with its 20-day average of 0.17, with a z-score barely below zero. Call options dominate the mix — the ratio has only once touched 0.42 in the past year and spent much of late July and early August at or near zero puts. That is an options market with essentially no defensive hedging. The 52-week low PCR of 0.00 underscores how call-heavy this name runs structurally. There is no sign of anyone reaching for downside protection.
The fund's recent performance fits the broader quality-growth rotation. A 5.5% gain over the past month tracks the sector recovery after softer inflation readings in mid-August drew institutional flows back toward high-quality earnings compounders. QGRW's mandate — U.S. companies screened for quality metrics and earnings growth — positions it to benefit from exactly that kind of macro backdrop. No valuation multiples are available at the fund level, and there is no earnings calendar, which is typical for a passive ETF vehicle. Analyst coverage in the traditional sense does not apply here.
What to watch next is straightforward: whether the short interest growth rate — up 65% over the past month — continues or stalls. At 0.21% of float it remains structurally unimportant, but if shares short keep doubling monthly, it eventually becomes worth contextualising against the ETF's creation-redemption activity and any shifts in the underlying growth factor trade.
See the live data behind this article on ORTEX.
Open QGRW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
